Healthcare DIVE October 13, 2021
Dive Brief:
- More than 50% of Type 2 diabetes patients in the U.S. could be using a continuous glucose monitor to measure their blood sugar levels in the next three years, according to new research from Jefferies based on their survey of roughly 50 endocrinologists and general practitioners. That’s up from 30% of the U.S. Type 2 patients now using the technology.
- Insulin pump adoption among Type 2 patients in the U.S. is likely to reach more than 35% in the same time frame, nearly double the level in use today, the analysts also predict.
- The report comes as companies in the space eye the Type 2 market as their next big opportunity, as a recent CMS coverage change...
Today's Sponsors
Today's Sponsor